5-Dec-2024 12:02 PM CST - Forbes Bristol-Myers Squibb Buy Write Gets Healthy Dose Of Dividends In January If we earn a $0.63 per share dividend in early January, and then if BMY closes above $60 on January 17, we would be assigned and earn a total of $2.93 per share on $57.70 at risk, or 5.08%. Over a holding period of 43 days,
4-Dec-2024 8:33 AM CST - MSN Is Bristol-Myers Squibb Stock Outperforming the Nasdaq? Bristol-Myers Squibb Company (BMY), headquartered in New York and with a market cap of $121.6 billion, is a global leader in biopharmaceutical innovation. Known for its expertise in developing life-saving therapies across oncology,
19-Nov-2024 12:19 AM CST - Business Insider Truist Financial Reaffirms Their Buy Rating on Bristol-Myers Squibb (BMY) Currently, Bristol-Myers Squibb has an average volume of 10.93M. Based on the recent corporate insider activity of 38 insiders, corporate insider sentiment is neutral on the stock. Earlier this month, Samit Hirawat, the EVP,Chief Med.Offr.,Drug Dev of BMY ...
5-Dec-2024 12:02 PM CST - Forbes Bristol-Myers Squibb Buy Write Gets Healthy Dose Of Dividends In January If we earn a $0.63 per share dividend in early January, and then if BMY closes above $60 on January 17, we would be assigned and earn a total of $2.93 per share on $57.70 at risk, or 5.08%. Over a holding period of 43 days,
4-Dec-2024 8:33 AM CST - MSN Is Bristol-Myers Squibb Stock Outperforming the Nasdaq? Bristol-Myers Squibb Company (BMY), headquartered in New York and with a market cap of $121.6 billion, is a global leader in biopharmaceutical innovation. Known for its expertise in developing life-saving therapies across oncology,
19-Nov-2024 12:19 AM CST - Business Insider Truist Financial Reaffirms Their Buy Rating on Bristol-Myers Squibb (BMY) Currently, Bristol-Myers Squibb has an average volume of 10.93M. Based on the recent corporate insider activity of 38 insiders, corporate insider sentiment is neutral on the stock. Earlier this month, Samit Hirawat, the EVP,Chief Med.Offr.,Drug Dev of BMY ...
